亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A hierarchical tumor-targeting strategy for eliciting potent antitumor immunity against triple negative breast cancer

癌症研究 三阴性乳腺癌 材料科学 免疫 免疫系统 乳腺肿瘤 医学 乳腺癌 癌症 免疫学 内科学
作者
Minzhao Lin,Yujun Cai,Gengjia Chen,Huihai Zhong,Bo Li,Li Tan,Zecong Xiao,Xintao Shuai
出处
期刊:Biomaterials [Elsevier BV]
卷期号:296: 122067-122067 被引量:18
标识
DOI:10.1016/j.biomaterials.2023.122067
摘要

Triple negative breast cancer (TNBC) as a highly aggressive and metastatic malignancy lacks targeting therapies nowadays. Moreover, although immune checkpoint blockade (ICB) is known to trigger anti-tumor immune response, most TNBC falls into the immunologically "cold" category unsuitable for ICB therapy due to insufficient lymphocyte infiltration. Herein, we develop a hierarchical targeting strategy for preparing a core-shell-structural nanodrug to concurrently block the programmed death ligand 1 (PD-L1) and deliver a stimulator of interferon gene (STING) agonist into tumor-infiltrating antigen-presenting cells (APCs). The nanodrug complexed the interferon stimulatory DNA (ISD) for STING activation in its core, conjugated PD-L1 antibody (aPD-L1) on its shell through a matrix metalloproteinase-2 (MMP-2) substrate peptide, and incorporated "hidden" mannose in its sublayer. Through aPD-L1-mediated active targeting of tumor cells and tumor-infiltrating APCs, the nanodrug efficiently accumulated in tumor sites. Then, the PD-L1-conjugating peptide was cleaved by tumor-enriched MMP-2, leaving aPD-L1 on target cells for ICB while exposing mannose to mediate targeted delivery of ISD into tumor-infiltrating dendritic cells (DCs) and tumor-associated macrophages (TAMs). Activating the STING signaling in DCs and TAMs not only stimulated the APCs maturation to prime anti-tumor immunity but also induced their chemokine secretion to promote tumor infiltration of anti-tumor effector T cells, thus sensitizing TNBC to the ICB therapy. Consequently, a potent antitumor immunity was evoked to effectively inhibit the tumor growth and metastasis in mice bearing orthotopic 4T1 breast cancer, showing the great potential in treating immunologically "cold" tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
8秒前
madeleinli的应助被纯情的阁采纳,获得10
22秒前
慕青的应助被纯情的阁采纳,获得10
22秒前
madeleinli的应助被纯情的阁采纳,获得10
23秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
23秒前
23秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
23秒前
小蘑菇的应助被纯情的阁采纳,获得10
23秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
24秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
24秒前
24秒前
单纯冰菱完成签到,获得积分10
26秒前
33秒前
火星上的山柳完成签到,获得积分10
35秒前
38秒前
大个的应助被Eva小飞鱼采纳,获得10
53秒前
称心的忆山完成签到,获得积分10
56秒前
1分钟前
agathahqs的应助被纯情的阁采纳,获得30
1分钟前
agathahqs的应助被纯情的阁采纳,获得10
1分钟前
agathahqs的应助被纯情的阁采纳,获得10
1分钟前
agathahqs的应助被纯情的阁采纳,获得10
1分钟前
null的应助被纯情的阁采纳,获得10
1分钟前
null的应助被纯情的阁采纳,获得10
1分钟前
奔跑的应助被纯情的阁采纳,获得10
1分钟前
1分钟前
冷傲的中恶完成签到,获得积分10
1分钟前
敏感兰完成签到,获得积分10
1分钟前
double_sweet完成签到,获得积分10
1分钟前
Benhnhk21完成签到,获得积分10
1分钟前
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
顾矜的应助被纯情的阁采纳,获得10
1分钟前
完美的飞兰完成签到,获得积分10
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
2分钟前
暴躁的尔柳完成签到,获得积分10
2分钟前
2分钟前
阔达之卉完成签到 ,获得积分10
2分钟前
欢喜的小蕾完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158827
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748395
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2552000
邀请新用户注册赠送积分活动 2471370